Compare Apple Inc (AAPL) vs McKesson Corporation (MCK) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Apple Inc vs McKesson Corporation — how do they compare? Apple Inc trades at $313.17 (market cap $4.56T), while McKesson Corporation trades at $817.45 (market cap $94.52B). The key difference: Apple Inc is far larger — about 48.2× McKesson Corporation's market cap, and McKesson Corporation pays the higher dividend (0.41%). Which is the better fit depends on your goals.
| AAPL | MCK | |
|---|---|---|
Market Cap | $4.56T | $94.52B |
Volume | 100,358,844 | — |
Sector | Technology | Health |
52-Week High | $315.20 | $995.69 |
52-Week Low | $202.38 | $659.01 |
Enterprise Value | $4.58T | $99.16B |
Dividend Yield | 0.35% | 0.41% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Apple (AAPL) trades at $313.27, up 0.2% today, with a bullish technical outlook and strong institutional support. The stock shows robust fundamentals with 2025 revenue of $416.16B and net income of $112.01B, though valuation ratios like P/E of 37.61 are elevated. Recent news highlights AI integration via Alphabet's Gemini and ongoing retail adjustments, including store closures amid union disputes.
Outlook remains positive with analyst consensus targeting $329.62, but risks include high valuation sensitivity and competitive pressures. Earnings have consistently beaten estimates, supporting growth potential, yet investors should monitor margin pressures and regulatory scrutiny in key markets.
McKesson (MCK) trades at $807.33, up 2.67% with strong bullish momentum. The stock shows robust fundamentals with consistent earnings beats and revenue growth from $309B to $359B in 2025. Technical indicators signal bullish momentum with price above key support levels. Recent news highlights McKesson's growth in specialty pharma and oncology services, supported by positive analyst sentiment.
Outlook remains positive with 80% analyst buy ratings and $932.83 consensus price target, offering 15% upside. Risks include policy pressures and margin compression, but diversified portfolio and investment-grade rating provide stability. Earnings momentum and strategic investments position MCK for continued growth in healthcare distribution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Apple Inc
Apple Inc. designs, manufactures, and markets personal computers and related personal computing and mobile communication devices along with a variety of related software, services, peripherals, and networking solutions. Apple sells its products worldwide through its online stores, its retail stores, its direct sales force, third-party wholesalers, and resellers.
Read more on AAPL →About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →
